The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer

References

• Aggarwal, B. B. and Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol 71:1397–1421.
   PubMed Web of Science ®Google Scholar
• Akhter, M., Inoue, M., Kurahashi, N., et al. (2008). Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol. Biomarkers Prev. 17:2128–2135.
   PubMed Web of Science ®Google Scholar
• Akhter, M., Iwasaki, M., Yamaji, T., et al. (2009). Dietary isoflavone and the risk of colorectal adenoma: A case-control study in Japan. Br. J. Cancer. 100:1812–1816.
   PubMed Web of Science ®Google Scholar
• Allin, K. H., Bojesen, S. E. and Nordestgaard, B. G. (2009). Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J. Clin. Oncol. 27:2217–2224.
   PubMed Web of Science ®Google Scholar
• Arts, I. C. W., Jacobs Jr, D. R., Gross, M., et al. (2002). Dietary catechins and cancer incidence among postmenopausal women: The Iowa Women's Health Study (United States). Cancer Causes Control. 13:373–382.
   PubMed Web of Science ®Google Scholar
• Azcarate-Peril, M. A., Sikes, M. and Bruno-Barcena, J. M. (2011). The intestinal microbiota, gastrointestinal environment and colorectal cancer: A putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver Physiol. 301:401–424.
   PubMed Web of Science ®Google Scholar
• Baek, S. J., Kim, J. S., Jackson, F. R., et al. (2004). Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis. 25:2425–2432.
   PubMed Web of Science ®Google Scholar
• Balkwill, F. (2009). Tumour necrosis factor and cancer. Nat. Rev. Cancer. 9:361–371.
   PubMed Web of Science ®Google Scholar
• Baral, R., Bose, A., Ray, C., et al. (2009). Association of early phase of colorectal carcinogenesis with STAT3 activation and its relevance in apoptosis regulation. Exp. Mol. Pathol. 87:36–41.
   PubMed Web of Science ®Google Scholar
• Barault, L., Veyrie, N., Jooste, V., et al. (2008). Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int. J. Cancer. 122:2255–2259.
   PubMed Web of Science ®Google Scholar
• Belluco, C., Nitti, D., Frantz, M., et al. (2000). Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann. Surg. Oncol. 7:133–138.
   PubMed Web of Science ®Google Scholar
• Berghella, A. M., Pellegrini, P., DelBeato, T., et al. (1997). IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. Cancer Biother. Radiopharm. 12:265–272.
   PubMed Web of Science ®Google Scholar
• Bharti, A. C., Donato, N. and Aggarwal, B. B. (2003). Curcurnin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 171:3863–3871.
   PubMed Web of Science ®Google Scholar
• Biesalski, H. K. (2007). Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care. 10:724–728.
   PubMed Web of Science ®Google Scholar
• Bingham, S. A., Day, N. E. and Luben, R. (2003). Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study (vol 361, pg 1496, 2003). Lancet. 362:1000.
   Web of Science ®Google Scholar
• Bobe, G., Albert, P. S., Sansbury, L. B., et al. (2010a). Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev. Res. 3:764–775.
   PubMed Web of Science ®Google Scholar
• Bobe, G., Murphy, G., Albert, P. S., et al. (2010b). Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br. J. Cancer. 103:1453–1461.
   PubMed Web of Science ®Google Scholar
• Bobe, G., Sansbury, L. B., Albert, P. S., et al. (2008). Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol. Biomarkers Prev. 17:1344–1353.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., et al. (1999). Stat3 as an oncogene. Cell. 98:295–303.
   PubMed Web of Science ®Google Scholar
• Budhathoki, S., Joshi, A. M., Ohnaka, K., et al. (2011). Soy food and isoflavone intake and colorectal cancer risk: The Fukuoka Colorectal Cancer Study. Scand. J. Gastroenterol. 46:165–172.
   PubMed Web of Science ®Google Scholar
• Burkitt, D. P. (1969). Related disease–related cause. Lancet. 2:1229.
   PubMed Web of Science ®Google Scholar
• Cairns, S. R., Scholefield, J. H., Steele, R. J., et al. (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 59:666–689.
   PubMed Web of Science ®Google Scholar
• Camuesco, D., Comalada, M., Rodriguez-Cabezas, M. E., et al. (2004). The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 143:908–918.
   PubMed Web of Science ®Google Scholar
• Chan, A. T. and Giovannucci, E. L. (2010). Primary prevention of colorectal cancer. Gastroenterology. 138:2029–2040.
   PubMed Web of Science ®Google Scholar
• Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., et al. (2005). Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 294:914–923.
   PubMed Web of Science ®Google Scholar
• Chan, D., Lau, R., Aune, D., et al. (2011). The WCRF/AICR continuous update project: Dietary fibre intake and colorectal cancer incidence. J. Epidemiol. Commun. Health. 65:A97.
   Web of Science ®Google Scholar
• Chechlinska, Magdalena, Magdalena Kowalewska and Radoslawa Nowak. (2010). Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nature Reviews Cancer 10.1:2–3.
   Google Scholar
• Cho, E. Y., Smith-Warner, S. A., Ritz, J., et al. (2004). Alcohol intake and colorectal cancer: A pooled analysis of 8 cohort studies. Ann. Intern. Med. 140:603–613.
   PubMed Web of Science ®Google Scholar
• Chun, O. K., Chung, S. J., Claycombe, K. J., et al. (2008). Serum c-reactive protein concentrations are inversely associated with dietary flavonoid intake in US adults. J. Nutr. 138:753–760.
   PubMed Web of Science ®Google Scholar
• Chung, Y. C., Chaen, Y. L. and Hsu, C. P. (2006). Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. Anticancer Res. 26:3905–3911.
   PubMed Web of Science ®Google Scholar
• Chung, Y. C. and Chang, Y. F. (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg. Oncol. 83:222–226.
   PubMed Web of Science ®Google Scholar
• Church, R. D., Fleshman, J. W. and McLeod, H. L. (2003). Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Br. J. Surg. 90:1055–1067.
   PubMed Web of Science ®Google Scholar
• Colbert, L. H., Hartman, T. J., Malila, N., et al. (2001). Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol. Biomarkers Prev. 10:265–268.
   PubMed Web of Science ®Google Scholar
• Colditz, G. A., Cannuscio, C. C. and Frazier, A. L. (1997). Physical activity and reduced risk of colon cancer: Implications for prevention. Cancer Causes Control. 8:649–667.
   PubMed Web of Science ®Google Scholar
• Cole, B. F., Logan, R. F., Halabi, S., et al. (2009). Aspirin for the chemoprevention of colorectal adenomas: Meta-analysis of the randomized trials. J. Natl. Cancer Inst. 101:256–266.
   PubMed Web of Science ®Google Scholar
• Colotta, F., Allavena, P., Sica, A., et al. (2009). Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis. 30:1073–1081.
   PubMed Web of Science ®Google Scholar
• Cotterchio, M., Boucher, B. A., Manno, M., et al. (2006). Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J. Nutr. 136:3046–3053.
   PubMed Web of Science ®Google Scholar
• CRUK. (2012a). Bowel Cancer Mortality Statistics. Cancer Research UK, London. Available from http://info.cancerresearchuk.org/cancerstats/types/bowel/mortality. Accessed March 2014.
   Google Scholar
• CRUK. (2012b). Bowel Cancer Survival Statistics. Cancer Research UK, London. Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/survival/#stage. Accessed March 2014.
   Google Scholar
• Danbara, N., Yuri, T., Tsujita-Kyutoku, M., et al. (2005). Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res. 25:2269–2276.
   PubMed Web of Science ®Google Scholar
• De Bacquer, D., Clays, E., Delanghe, J., et al. (2006). Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis. 189:428–435.
   PubMed Web of Science ®Google Scholar
• Dimberg, J., Samuelsson, A., Hugander, A., et al. (1999). Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut. 45:730–732.
   PubMed Web of Science ®Google Scholar
• Djuric, Z., Severson, R. K. and Kato, I. (2012). Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr. Cancer Int. J. 64:351–360.
   PubMed Web of Science ®Google Scholar
• Dvorak, H. F. (1986). Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650–1659.
   PubMed Web of Science ®Google Scholar
• Ellul, P., Fogden, E., Simpson, C. L., et al. (2010). Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: First round data from the first centre. Colorectal Dis. 12:420–422.
   PubMed Web of Science ®Google Scholar
• Elmali, N., Baysal, O., Harma, A., et al. (2007). Effects of resveratrol in inflammatory arthritis. Inflammation. 30:1–6.
   PubMed Web of Science ®Google Scholar
• Fearon, E. R. (2011). Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6:479–507.
   PubMed Web of Science ®Google Scholar
• Flossmann, E., Rothwell, P. M. and Trial, B. D. A. (2007). Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet. 369:1603–1613.
   PubMed Web of Science ®Google Scholar
• Fujita, T., Matsui, M., Takaku, K., et al. (1998). Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res. 58:4823–4826.
   PubMed Web of Science ®Google Scholar
• Galizia, G., Orditura, M., Romano, C., et al. (2002). Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin. Immunol. 102:169–178.
   PubMed Web of Science ®Google Scholar
• Gonzalez, R., Ballester, I., Lopez-Posadas, R., et al. (2011). Effects of flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci. Nutr. 51:331–362.
   PubMed Web of Science ®Google Scholar
• Halliwell, B., Zhao, K. C. and Whiteman, M. (2000). The gastrointestinal tract: A major site of antioxidant action? Free Radical Res. 33:819–830.
   PubMed Web of Science ®Google Scholar
• Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell. 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hanai, H., Iida, T., Takeuchi, K., et al. (2006). Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 4:1502–1506.
   PubMed Web of Science ®Google Scholar
• Heikkila, K., Ebrahim, S. and Lawlor, D. A. (2008). Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur. J. Cancer. 44:937–945.
   PubMed Web of Science ®Google Scholar
• Hewitson, P., Glasziou, P., Irwig, L., et al. (2007). Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst. Rev. (1):CD001216.
   PubMed Web of Science ®Google Scholar
• Hirsch, E., Katanaev, V. L., Garlanda, C., et al. (2000). Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 287:1049–1053.
   PubMed Web of Science ®Google Scholar
• Hodge, D. R., Hurt, E. M. and Farrar, W. L. (2005). The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer. 41:2502–2512.
   PubMed Web of Science ®Google Scholar
• Hoensch, H., Groh, B., Edler, L., et al. (2008). Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J. Gastroenterol. 14:2187–2193.
   PubMed Web of Science ®Google Scholar
• Jeong, J. H., An, J. Y., Kwon, Y. T., et al. (2009). Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J. Cell. Biochem. 106:73–82.
   PubMed Web of Science ®Google Scholar
• Jess, T., Simonsen, J., Jorgensen, K. T., et al. (2012). Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 143:375.
   PubMed Web of Science ®Google Scholar
• Johnson, C. C., Hayes, R. B., Schoen, R. E., et al. (2010). Non-steroidal anti-inflammatory drug use and colorectal polyps in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Gastroenterol. 105:2646–2655.
   PubMed Web of Science ®Google Scholar
• Johnson, S. M., Gulhati, P., Arrieta, I., et al. (2009). Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res. 29:3185–3190.
   PubMed Web of Science ®Google Scholar
• Kai, H., Kitadai, Y., Kodama, M., et al. (2005). Involvement of proinflammatory cytokines IL-1 beta and IL-6 in progression of human gastric carcinoma. Anticancer Res. 25:709–713.
   PubMed Web of Science ®Google Scholar
• Kaur, J. and Sanyal, S. N. (2010). PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: Chemoprevention by diclofenac. Tumor Biol. 31:623–631.
   PubMed Web of Science ®Google Scholar
• Kawamori, T., Uchiya, N., Sugimura, T., et al. (2003). Enhancement of colon carcinogenesis by prostaglandin E-2 administration. Carcinogenesis. 24:985–990.
   PubMed Web of Science ®Google Scholar
• Kim, H., Kong, H. S., Choi, B., et al. (2005). Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharmaceut. Res. 22:1499–1509.
   PubMed Web of Science ®Google Scholar
• Kim, S., Keku, T. O., Martin, C., et al. (2008). Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 68:323–328.
   PubMed Web of Science ®Google Scholar
• Kinoshita, T., Ito, H. and Miki, C. (1999). Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer. 85:2526–2531.
   PubMed Web of Science ®Google Scholar
• Knupfer, H. and Preiss, R. (2010). Serum interleukin-6 levels in colorectal cancer patients—a summary of published results. Int. J. Colorectal Dis. 25:135–140.
   PubMed Web of Science ®Google Scholar
• Kojima, M., Morisaki, T., Sasaki, N., et al. (2004). Increased nuclear factor-kappa B activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 24:675–681.
   PubMed Web of Science ®Google Scholar
• Kundu, J. K., Na, H. K., Chun, K. S., et al. (2003). Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr. 133:3805S–3810S.
   PubMedGoogle Scholar
• Kyle, J. A., Sharp, L., Little, J., et al. (2010). Dietary flavonoid intake and colorectal cancer: A case-control study. Br. J. Nutr. 103:429–436.
   PubMed Web of Science ®Google Scholar
• Ladabaum, U., Clarke, C. A., Press, D. J., et al. (2014). Colorectal cancer incidence in Asian populations in California: Effect of nativity and neighborhood-level factors. Am. J. Gastroenterol. 109:579–588.
   PubMed Web of Science ®Google Scholar
• Le, N. H. and Fodde, R. (2008). Tumour-stroma interactions in colorectal cancer: Converging on beta-catenin activation and cancer stemness. Br. J. Cancer. 98:1886–1893.
   PubMed Web of Science ®Google Scholar
• Lee, H., Herrmann, A., Deng, J. H., et al. (2009). Persistently activated stat3 maintains constitutive NF-kappa B activity in tumors. Cancer Cell. 15:283–293.
   PubMed Web of Science ®Google Scholar
• Lee, K. M., Hwang, M. K., Lee, D. E., et al. (2010). Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J. Agric. Food Chem. 58:5815–5820.
   PubMed Web of Science ®Google Scholar
• Li, B., Vincent, A., Cates, J., et al. (2009). Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res. 69:338–348.
   PubMed Web of Science ®Google Scholar
• Li, M., Zhang, Z., Hill, D. L., et al. (2007). Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 67:1988–1996.
   PubMed Web of Science ®Google Scholar
• Liang, P. S., Chen, T. Y. and Giovannucci, E. (2009). Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis. Int. J. Cancer. 124:2406–2415.
   PubMed Web of Science ®Google Scholar
• Liao, X. Y., Lochhead, P., Nishihara, R., et al. (2012a). Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N. Engl. J. Med. 367:1596–1606.
   PubMed Web of Science ®Google Scholar
• Liao, X. Y., Morikawa, T., Lochhead, P., et al. (2012b). Prognostic role of PIK3CA mutation in colorectal cancer: Cohort study and literature review. Clin. Cancer Res. 18:2257–2268.
   PubMed Web of Science ®Google Scholar
• Lu, H. T., Ouyang, W. M. and Huang, C. S. (2006). Inflammation, a key event in cancer development. Mol. Cancer Res. 4:221–233.
   PubMed Web of Science ®Google Scholar
• Manna, S. K., Mukhopadhyay, A. and Aggarwal, B. B. (2000). Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:6509–6519.
   PubMed Web of Science ®Google Scholar
• Mantovani, A., Allavena, P., Sica, A. and Balkwill, F (2008). Cancer-related inflammation. Nature. 454:436–444.
   Google Scholar
• Martinez-Florez, S., Gutierrez-Fernandez, B., Sanchez-Campos, S., et al. (2005). Quercetin attenuates nuclear factor-kappa B activation and nitric oxide production in interleukin-1 beta-activated rat hepatocytes. J. Nutr. 135:1359–1365.
   PubMed Web of Science ®Google Scholar
• Marzocchella, L., Fantini, M., Benvenuto, M., et al. (2011). Dietary flavonoids: Molecular mechanisms of action as anti-inflammatory agents. Recent Pat. Inflamm. Allergy Drug Discov. 5:200–220.
   PubMedGoogle Scholar
• Masuda, M., Suzui, N. and Weinstein, I. B. (2001). Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 7:4220–4229.
   PubMed Web of Science ®Google Scholar
• McAllister, S. S. and Weinberg, R. A. (2014). The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell. Biol. 16:717–727.
   PubMed Web of Science ®Google Scholar
• Mutoh, M., Takahashi, M., Fukuda, K., et al. (2000). Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis. 21:959–963.
   PubMed Web of Science ®Google Scholar
• Naugler, W. E. and Karin, M. (2008). The wolf in sheep's clothing: The role of interieukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 14:109–119.
   PubMed Web of Science ®Google Scholar
• Nikiteas, N. I., Tzanakis, N., Gazouli, M., et al. (2005). Serum IL-6, TNF alpha and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J. Gastroenterol. 11:1639–1643.
   PubMed Web of Science ®Google Scholar
• Norat, T., Bingham, S., Ferrari, P., et al. (2005). Meat, fish, and colorectal cancer risk: The European prospective investigation into cancer and nutrition. J. Natl. Cancer Inst. 97:906–916.
   PubMed Web of Science ®Google Scholar
• Oz, H. S., Chen, T. S., McClain, C. J., et al. (2005). Antioxidants as novel therapy in a murine model of colitis. J. Nutr. Biochem. 16:297–304.
   PubMed Web of Science ®Google Scholar
• Pages, F., Galon, J., Dieu-Nosjean, M. C., et al. (2010). Immune infiltration in human tumors: A prognostic factor that should not be ignored. Oncogene. 29:1093–1102.
   PubMed Web of Science ®Google Scholar
• Park, J. H., McMillan, D. C., Horgan, P. G., et al. (2014). The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer. Cancer Treat. Rev. 40:68–77.
   PubMed Web of Science ®Google Scholar
• Park, J. K., Hong, R., Kim, K. J., et al. (2008). Significance of p-STAT3 expression in human colorectal adenocarcinoma. Oncol. Rep. 20:597–604.
   PubMed Web of Science ®Google Scholar
• Park, J. Y., Mitrou, P. N., Keogh, R. H., et al. (2012). Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int. J. Obesity. 36:107–118.
   Web of Science ®Google Scholar
• Patterson, R. E., Neuhouser, M. L., Hedderson, M. M., et al. (2003). Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J. Am. Diet. Assoc. 103:323–328.
   PubMed Web of Science ®Google Scholar
• Pellegrini, P., Berghella, A. M., Contasta, I., et al. (2006). The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. Cancer Biother. Radiopharm. 21:443–467.
   PubMed Web of Science ®Google Scholar
• Popivanova, B. K., Kitamura, K., Wu, Y., et al. (2008). Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118:560–570.
   PubMed Web of Science ®Google Scholar
• Prizment, A. E., Anderson, K. E., Visvanathan, K., et al. (2011). Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol. Biomarkers Prev. 20:297–307.
   PubMed Web of Science ®Google Scholar
• Qu, H. Y., Madl, R. L., Takemoto, D. J., et al. (2005). Lignans are involved in the antitumor activity of wheat bran in colon cancer SW480 cells. J. Nutr. 135:598–602.
   PubMed Web of Science ®Google Scholar
• Reedy, J., Haines, P. S., Steckler, A., et al. (2005). Qualitative comparison of dietary choices and dietary supplement use among older adults with and without a history of colorectal cancer. J. Nutr. Educ. Behav. 37:252–258.
   PubMed Web of Science ®Google Scholar
• Rossi, M., Negri, E., Talamini, R., et al. (2006). Flavonoids and colorectal cancer in Italy. Cancer Epidemiol. Biomarkers Prev. 15:1555–1558.
   PubMed Web of Science ®Google Scholar
• Roxburgh, C. S. D. and McMillan, D. C. (2012). The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat. Rev. 38:451–466.
   PubMed Web of Science ®Google Scholar
• Samuels, Y., Wang, Z. H., Bardelli, A., et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science. 304:554.
   PubMed Web of Science ®Google Scholar
• Sarkar, F. H. and Li, Y. W. (2008). NF-kappaB: A potential target for cancer chemoprevention and therapy. Front. Biosci. (Landmark) 13:2950–2959.
   PubMed Web of Science ®Google Scholar
• Senovilla, L., Vacchelli, E., Galon, J., et al. (2012). Trial watch prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 1:1323–1343.
   PubMed Web of Science ®Google Scholar
• Sheehan, K. M., Sheahan, K., O'Donoghue, D. P., et al. (1999). The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 282:1254–1257.
   PubMed Web of Science ®Google Scholar
• Shishodia, S., Sethi, G. and Aggarwal, B. B. (2005). Curcumin: Getting back to the roots. Ann. N. Y. Acad. Sci. 1056:206–217.
   PubMed Web of Science ®Google Scholar
• Simons, C. C. J. M., Hughes, L. A. E., Arts, I. C. W., et al. (2009). Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. Int. J. Cancer. 125:2945–2952.
   PubMed Web of Science ®Google Scholar
• Singh, S. and Aggarwal, B. B. (1995). Activation of transcription factor Nf-kappa-B is suppressed by curcumin (Diferuloylmethane) (Vol 270, Pg 24995, 1995). J Biol. Chem. 270:30235.
   Web of Science ®Google Scholar
• Song, Y. Q., Manson, J. E., Buring, J. E., et al. (2005). Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: A prospective study and cross-sectional analysis. J. Am. Coll. Nutr. 24:376–384.
   PubMed Web of Science ®Google Scholar
• Steele, R. J., McClements, P., Watling, C., et al. (2012). Interval cancers in a FOBT-based colorectal cancer population screening programme: Implications for stage, gender and tumour site. Gut. 61:576–581.
   PubMed Web of Science ®Google Scholar
• Stephanou, A., Brar, B. K., Knight, R. A., et al. (2000). Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 7:329–330.
   PubMed Web of Science ®Google Scholar
• Steptoe, A., Gibson, E. L., Vuononvirta, R., et al. (2007). The effects of chronic tea intake on platelet activation and inflammation: A double-blind placebo controlled trial. Atherosclerosis. 193:277–282.
   PubMed Web of Science ®Google Scholar
• Stryker, S. J., Wolff, B. G., Culp, C. E., et al. (1987). Natural-history of untreated colonic polyps. Gastroenterology. 93:1009–1013.
   PubMed Web of Science ®Google Scholar
• Suh, Y., Afaq, F., Johnson, J. J., et al. (2009). A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappa B-signaling pathways. Carcinogenesis. 30:300–307.
   PubMed Web of Science ®Google Scholar
• Taketo, M. M. (1998). COX-2 and colon cancer. Inflamm. Res. 47:S112–S116.
   PubMed Web of Science ®Google Scholar
• Tang, L. Q., Wei, W. and Wang, X. Y. (2007). Effects and mechanisms of catechin for adjuvant arthritis in rats. Adv. Ther. 24:679–690.
   PubMed Web of Science ®Google Scholar
• Tangrea, J. A., Albert, P. S., Lanza, E., et al. (2003). Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control. 14:403–411.
   PubMed Web of Science ®Google Scholar
• Terzic, J., Grivennikov, S., Karin, E., et al. (2010). Inflammation and colon cancer. Gastroenterology. 138:2101–2119.
   PubMed Web of Science ®Google Scholar
• Theodoratou, E., Farrington, S. M., Tenesa, A., et al. (2014). Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population. Eur. J Cancer Prev. 23:8–17.
   PubMed Web of Science ®Google Scholar
• Theodoratou, E., Kyle, J., Cetnarskyj, R., et al. (2007). Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 16:684–693.
   PubMed Web of Science ®Google Scholar
• Tsujii, M., Kawano, S. and DuBois, R. N. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U. S. Am. 94:3336–3340.
   PubMed Web of Science ®Google Scholar
• Uddin, S., Ahmed, M., Hussain, A., et al. (2010). Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Int. J. Cancer. 126:382–394.
   PubMed Web of Science ®Google Scholar
• Umesalma, S. and Sudhandiran, G. (2010). Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappa B, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin. Pharmacol. Toxicol. 107:650–655.
   PubMed Web of Science ®Google Scholar
• Wang, J. X., Zhang, Q. Y., Jin, S., et al. (2008). Genistein modulate immune responses in collagen-induced rheumatoid arthritis model. Maturitas. 59:405–412.
   PubMed Web of Science ®Google Scholar
• Wang, L. S., Tu, Y. C., Lian, T. W., et al. (2006). Distinctive antioxidant and antiinflammatory effects of flavonols. J. Agric. Food Chem. 54:9798–9804.
   PubMed Web of Science ®Google Scholar
• Ward, H. A., Kuhnle, G. G. C., Mulligan, A. A., et al. (2010). Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am. J. Clin. Nutr. 91:440–448.
   PubMed Web of Science ®Google Scholar
• WCRF. (2011). Colorectal Cancer 2011 Report. Food Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. World Cancer Research Fund, London. Available from http://www.wcrf.org/sites/default/files/Colorectal-Cancer-2011-Report.pdf. Accessed November 2014.
   Google Scholar
• Whitehall, V. L. J., Rickman, C., Bond, C. E., et al. (2012). Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int. J. Cancer. 131:813–820.
   PubMed Web of Science ®Google Scholar
• Wolin, K. Y., Yan, Y., Colditz, G. A., et al. (2009). Physical activity and colon cancer prevention: A meta-analysis. Br. J. Cancer. 100:611–616.
   PubMed Web of Science ®Google Scholar
• Wung, B. S., Hsu, M. C., Wu, C. C., et al. (2005). Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: Effects on the inhibition of STAT3 phosphorylation. Life Sci. 78:389–397.
   PubMed Web of Science ®Google Scholar
• Yang, F. J., Oz, H. S., Barve, S., et al. (2001). The green tea polyphenol (−)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60:528–533.
   PubMed Web of Science ®Google Scholar
• Yang, G., Shu, X. O., Li, H. L., et al. (2009). Prospective cohort study of soy food intake and colorectal cancer risk in women. Am. J. Clin. Nutr. 89:577–583.
   PubMed Web of Science ®Google Scholar
• Yu, H., Pardoll, D. and Jove, R. (2009). STATs in cancer inflammation and immunity: A leading role for STAT3. Nat. Rev. Cancer. 9:798–809.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros, R., Not, C., Guino, E., et al. (2013). Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer Causes Control. 24:549–557.
   PubMed Web of Science ®Google Scholar